Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Eli Lilly (NY:LLY)

1,071.64 -4.84 (-0.45%)

Official Closing Price Updated: 7:00 PM EST, Dec 23, 2025 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	2,108,563
Open	1,063.50
Bid (Size)	1,070.51 (40)
Ask (Size)	1,073.00 (80)
Prev. Close	1,076.48
Today's Range	1,063.50 - 1,088.48
52wk Range	623.78 - 1,111.99
Shares Outstanding	956,580,893
Dividend Yield	0.56%

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Novo Nordisk Stock Soars as "Wegovy Pill" Gains FDA Approval, Reshaping Obesity Market

Today 17:07 EST

Shares of Novo Nordisk (NYSE: NVO) surged more than 8% in early trading on December 23, 2025, after the pharmaceutical giant secured a landmark FDA approval for its high-dose oral semaglutide, branded...

Via MarketMinute

Resilient Prosperity: Blowout Q3 GDP Growth Ignites Year-End Market Surge Amid 'No-Landing' Fears

Today 17:05 EST

The United States economy defied gravity in the third quarter of 2025, posting a staggering 4.3% annualized growth rate that has sent shockwaves through global financial markets. Released on December...

Via MarketMinute

Performance

YTD	+37.7%	+37.7%
1 Month	+0.1%	+0.1%
3 Month	+43.5%	+43.5%
6 Month	+37.7%	+37.7%
1 Year	+34.6%	+34.6%

More News

Stock Market Today, Dec. 23: Novo Nordisk Surges After FDA Approves Oral Wegovy Weight Loss Pill ↗

Today 17:02 EST

Via The Motley Fool

Novo Nordisk’s Worst Year In Over Four Decades May Be Ending — Thanks To A Weight-Loss Pill ↗

Today 8:14 EST

Via Stocktwits

Fitch Sees Stable 2026 Outlook For Global Pharma — But Warns Trump Drug Pricing Push Poses Profit Risk ↗

Today 14:15 EST

Via Stocktwits

The Next Big Buyout? Abivax Emerges as a Premier M&A Contender for 2026 Amidst Biotech Consolidation Wave

Today 14:13 EST

Via MarketMinute

Novo Nordisk Breaks the Mold: Oral Obesity Breakthrough Sends Shares to New Heights as Pharma Landscape Shifts

Today 14:05 EST

Via MarketMinute

Novo Nordisk's Wegovy Pill Shakes Up Rivalry With Eli Lilly, Puts Health Care ETFs In Focus ↗

Today 14:04 EST

Via Benzinga

What's Going On With Eli Lilly Stock Today? ↗

Today 12:25 EST

Via Benzinga

Thin Trading and High Hopes: Markets Eye a 'Santa Claus Rally' as 2025 Draws to a Close

Today 11:52 EST

Via MarketMinute

Santa Claus Rally Solidifies as S&P 500 Secures Third Consecutive Winning Session Amid Economic Resilience

Today 10:35 EST

Via MarketMinute

The Great Biotech Rebound: How Pricing Clarity Rescued the Drug Sector in 2025

Today 10:17 EST

Via MarketMinute

Eli Lilly Vs. Novo Nordisk: Which Stock Could Lead Pharma's 2026 Comeback ↗

Today 8:54 EST

Via Benzinga

Nasdaq, S&P 500 Futures Tread Caution Ahead Of GDP, Confidence Data: Why NVO, ZIM, SIDU Are On Traders' Radar Today ↗

Today 4:25 EST

Via Stocktwits

3 Reasons Investors Love Eli Lilly (LLY)

December 22, 2025

Via StockStory

Why Abivax Stock Was on Fire Today ↗

December 22, 2025

Via The Motley Fool

Novo Nordisk Jumps As FDA OKs Wegovy Pill As First-Ever Oral GLP-1 Weight Loss Drug ↗

December 22, 2025

Via Investor's Business Daily

Novo Nordisk Stock Soars After Hours As FDA Greenlights Wegovy Pill For Weight Loss ↗

December 22, 2025

Via Stocktwits

The Incretin Empire: Eli Lilly’s (LLY) Path to a $1 Trillion Market Cap and Beyond

December 22, 2025

Via PredictStreet

The Pfizer Pivot: A Deep-Dive into PFE’s 2025 Financial Recovery and Strategic Rebirth

December 22, 2025

Via PredictStreet

Eli Lilly - Momentum Near 52‑Week High As Trade Engine Flags Moderate Strength ↗

December 22, 2025

Via Talk Markets

Should You Forget Novo Nordisk and Buy This Magnificent High-Yield Drug Stock Instead? ↗

December 22, 2025

Via The Motley Fool

2 Profitable Stocks with Exciting Potential and 1 Facing Challenges

December 21, 2025

Via StockStory

ELI LILLY & CO (NYSE:LLY) Combines Strong Earnings Momentum with Bullish Technical Setup ↗

December 20, 2025

Via Chartmill

Dow Jones' Merck, Other Drugmakers Strike Drug-Pricing Bargains With Trump ↗

December 19, 2025

Via Investor's Business Daily

Frequently Asked Questions

Is Eli Lilly publicly traded?

Yes, Eli Lilly is publicly traded.

What exchange does Eli Lilly trade on?

Eli Lilly trades on the New York Stock Exchange

What is the ticker symbol for Eli Lilly?

The ticker symbol for Eli Lilly is LLY on the New York Stock Exchange

What is the current price of Eli Lilly?

The current price of Eli Lilly is 1,071.64

When was Eli Lilly last traded?

The last trade of Eli Lilly was at 12/23/25 07:00 PM ET

What is the market capitalization of Eli Lilly?

The market capitalization of Eli Lilly is 1,025.11B

How many shares of Eli Lilly are outstanding?

Eli Lilly has 1,025B shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.